4//SEC Filing
Ghoshal Kaushik 4
Accession 0001127602-25-009051
CIK 0000943819other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:19 PM ET
Size
20.1 KB
Accession
0001127602-25-009051
Insider Transaction Report
Form 4
RESMED INCRMD
Ghoshal Kaushik
Chief Commercial Officer, SaaS
Transactions
- Exercise/Conversion
ResMed Common Stock Options
2025-03-10−5,882→ 0 totalExercise: $211.76From: 2020-11-19Exp: 2027-11-19→ ResMed Common Stock (5,882 underlying) - Exercise/Conversion
ResMed Common Stock
2025-03-10$211.76/sh+105$22,235→ 9,999 total - Sale
ResMed Common Stock
2025-03-10$239.31/sh−9,745$2,332,096→ 9,725 total - Exercise/Conversion
ResMed Common Stock Options
2025-03-10−105→ 0 totalExercise: $211.76From: 2020-11-19Exp: 2027-11-19→ ResMed Common Stock (105 underlying) - Exercise/Conversion
ResMed Common Stock Options
2025-03-10−3,589→ 0 totalExercise: $146.34From: 2019-11-21Exp: 2026-11-21→ ResMed Common Stock (3,589 underlying) - Exercise/Conversion
ResMed Common Stock
2025-03-10$211.76/sh+5,882$1,245,572→ 19,470 total - Exercise/Conversion
ResMed Common Stock
2025-03-10$146.34/sh+169$24,731→ 9,894 total - Exercise/Conversion
ResMed Common Stock
2025-03-10$146.34/sh+3,589$525,214→ 13,588 total - Exercise/Conversion
ResMed Common Stock Options
2025-03-10−169→ 0 totalExercise: $146.34From: 2019-11-21Exp: 2026-11-21→ ResMed Common Stock (169 underlying)
Holdings
- 9,628(indirect: By Trust)
ResMed Common Stock
Footnotes (3)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $236.62 - $242.73. The price reported above reflects the weighted average sale price.
- [F3]Represents date options first become exercisable. Options vest 1/3 per year.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeother
Related Parties
1- filerCIK 0001881922
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:19 PM ET
- Size
- 20.1 KB